Vanguard Global Advisers
CHE icon

Vanguard Global Advisers’s Chemed CHE Stock Holding History

Vanguard Global Advisers’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39M Sell
5,129
-579
-10% -$243K ﹤0.01% 1145
2026
Q1 		$2.16M Buy
+5,708
New +$2.44M ﹤0.01% 1147

Other funds holding CHE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Vanguard Global Advisers's CHE Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Chemed (CHE) stake by 10% in Q2 2026, selling an estimated $243K and leaving 5,129 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1145.

Vanguard Global Advisers first reported a position in CHE in Q1 2026 and has held it in 2 quarters since. 522 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Vanguard Global Advisers held 5,129 shares of Chemed worth $2.39M as of Q2 2026.
  • Vanguard Global Advisers sold 579 Chemed shares in Q2 2026, an estimated $243K.
  • Chemed made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1145 holding.
  • Vanguard Global Advisers first reported a position in Chemed in Q1 2026 and has held it in 2 quarters since.
  • 522 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.